Evotec SE (ETR:EVT)
5.28
+0.17 (3.33%)
May 29, 2026, 5:35 PM CET
Evotec SE Employees
Evotec SE had 4,526 employees as of March 31, 2026. The number of employees decreased by 240 or -5.04% compared to the same quarter last year.
Employees
4,526
Change
-240
Growth
-5.04%
Revenue / Employee
€164,613
Profits / Employee
€42,836
Market Cap
908.30M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 4,526 | -240 | -5.04% |
| Dec 31, 2025 | 4,467 | -273 | -5.76% |
| Sep 30, 2025 | 4,788 | -219 | -4.37% |
| Jun 30, 2025 | 4,759 | -263 | -5.24% |
| Mar 31, 2025 | 4,766 | -289 | -5.72% |
| Dec 31, 2024 | 4,740 | -321 | -6.34% |
| Sep 30, 2024 | 5,007 | -79 | -1.55% |
| Jun 30, 2024 | 5,022 | -45 | -0.89% |
| Mar 31, 2024 | 5,055 | 103 | 2.08% |
| Dec 31, 2023 | 5,061 | 109 | 2.20% |
| Sep 30, 2023 | 5,086 | 371 | 7.87% |
| Jun 30, 2023 | 5,067 | 546 | 12.08% |
| Dec 31, 2022 | 4,952 | 754 | 17.96% |
| Sep 30, 2022 | 4,715 | 634 | 15.54% |
| Jun 30, 2022 | 4,521 | 607 | 15.51% |
| Mar 31, 2022 | 4,354 | 619 | 16.57% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 177,783 |
| Bayer Aktiengesellschaft | 87,757 |
| Siemens Healthineers AG | 73,800 |
| Merck KGaA | 59,077 |
| RHÖN-KLINIKUM Aktiengesellschaft | 19,184 |
| Drägerwerk AG & Co. KGaA | 16,033 |
| Gerresheimer AG | 13,535 |
| Redcare Pharmacy NV | 2,163 |
Evotec SE News
- 7 days ago - EQS-DD: Evotec SE: Dr. Cord Dohrmann, sell - Wallstreet:Online
- 16 days ago - Evotec SE (EVO) Issues â¬116.1M Convertible Bonds to Support Project Horizon - GuruFocus
- 17 days ago - Evotec SE Successfully Placed €116.1 Million Convertible Bonds - Accesswire
- 17 days ago - EQS-Adhoc: Evotec SE launches approximately EUR 125 million convertible bond offering - Wallstreet:Online
- 24 days ago - EQS-DD: Evotec SE: Paul Hitchin, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 24 days ago - EQS-DD: Evotec SE: Aurélie Dalbiez, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 24 days ago - EQS-DD: Evotec SE: Dr. Christian Wojczewski, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online
- 24 days ago - EQS-DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2025 pursuant Evotec’s remuneration system. - Wallstreet:Online